Developer docs
API playgroundTry for free, no card

Search company profiles

Elicit

Full company profile

uuid00007nu

Namestring
Elicit
Legal namestring
Elicit Research, PBC
Websiteurl
elicit.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Elicit is an AI-powered research assistant that uses large language models to help academic, pharmaceutical, biotech, policy, and other scientific researchers automate literature discovery, evidence extraction, and systematic review workflows. Founded in 2018 at the Ought research lab by Andreas Stuhlmüller (CEO, MIT PhD in cognitive science, Stanford postdoc) and Jungwon Byun (COO, ex-Head of Growth at Upstart, Yale economics), the company is incorporated as Elicit Research, PBC — a Delaware Public Benefit Corporation headquartered in Oakland, California with a distributed team across North America and Europe.

The platform is built around semantic search and retrieval-augmented generation across 138 million academic papers and 545,000 clinical trials, with keyword search support spanning PubMed and ClinicalTrials.gov. It is organized into five core modules — Search, Research Reports (customizable up to 80 papers), Systematic Literature Review (PRISMA 2020-compliant and benchmarked at 95–99% accuracy across 994 Cochrane reviews), Library, and Alerts — plus specialized modules for Clinical Trials, Research Agents (multi-step autonomous workflows), and a Mechanisms of Action content experience. Outputs are sentence-level citation-backed for verifiability, and the platform exposes programmatic access via the Elicit API (launched March 2026, tier-gated rate limits).

Revenue comes from a tiered SaaS subscription model (Basic free, Plus, Pro, Teams, Institutional, Enterprise) layered onto product-led self-serve signup, with a parallel enterprise field-sales motion targeting pharma, biotech, medtech, and life sciences organizations in the US and EMEA. The company has raised over $30 million in venture capital across a $9M seed round (September 2023, led by Fifty Years) and a $22M Series A (February 2025, led by Footwork and Spark Capital), with named customers including Formation Bio, Oxford PharmaGenesis, Genentech, Novartis, OpenAI, VDI/VDE, Harvard, MIT, and Stanford, and reports "millions of dollars of recurring revenue" roughly eighteen months after launching paid subscriptions.

Short descriptiontext

Elicit is an AI research assistant that uses LLMs to automate literature discovery, evidence extraction, and systematic reviews across 138 million academic papers and 545,000 clinical trials for academic, pharmaceutical, biotech, and policy researchers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersOakland, United States
HQ citystring
Oakland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI research assistant, systematic literature review, scientific paper search, evidence synthesis software, clinical trial analysis
Industry1 code
PRIMARYEDAFADAD
Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms
NAICS code2 codes
  • Educational Support Services611710
  • Research and Development in the Social Sciences and Humanities54172
SIC code1 code
  • Services-Prepackaged Software7372
Product category
AI Research Assistant Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription tiers
TypeSubscription Recurring
Description

Tiered SaaS subscription: Elicit Basic (free), Elicit Plus, Elicit Pro, Elicit Teams, Elicit Institutional, and Elicit Enterprise. Plus, Pro, Teams, Institutional, and Enterprise are paid subscriptions; Teams is geared at purchasers with a separate Services Agreement. Enterprise is quote-based via Talk to Sales.

elicit.com
2Enterprise contracts
TypeSubscription Recurring
Description

Large enterprise contracts with pharma, biotech, and life sciences organizations. Enterprise AEs are compensated on quota with OTE of $200K–$360K, suggesting seven-figure deal sizes and multi-year engagements. Land-and-expand motion: pilot programs, then multi-year, multi-team expansion.

elicit.com
3API access
TypeUsage Based
Description

API access is bundled into Pro, Teams, and Enterprise subscriptions — not sold as a standalone product. Usage is gated by rate limits: Pro users get 100 papers per search request and 100 search requests per day; Teams users get 200 papers per search request and 200 search requests per day. Report generation is limited by overall Elicit workflow quota.

elicit.com
4Freemium self-serve
TypeFreemium
Description

Free tier (Basic) provides unlimited searches for free users (since July 2024), serving as a top-of-funnel conversion engine to Plus, Pro, and Teams paid tiers.

elicit.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details5 tiers
1Elicit Basic — free tier with unlimited searches (phased out credits in July 2024)
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free for individual users; serves as the self-serve entry point.

elicit.com
2Elicit Plus — paid individual tier
ModelSubscriptionBilling cadenceMonthly
Notes

Subscription plan listed in Terms of Service; specific price not disclosed on the source pages reviewed.

elicit.com
3Elicit Pro — paid individual tier with API access
ModelSubscriptionBilling cadenceMonthly
Notes

Subscription plan listed in Terms of Service. API access: 100 papers per search request and 100 search requests per day (rolling 24-hour window).

elicit.com
4Elicit Teams — paid team subscription with API access
ModelSubscriptionBilling cadenceAnnual
Notes

Subject to a separate Services Agreement for Team Subscriptions. API access: 200 papers per search request and 200 search requests per day.

elicit.com
5Elicit Institutional and Enterprise — institutional/enterprise plans
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Institutional and Enterprise plans are subject to Authorized User Terms; Enterprise is quote-based via 'Talk to Sales'. API access available on Enterprise with rate limits tied to plan.

elicit.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Elicit is an AI research assistant platform that uses language models to help researchers find, analyze, and synthesize scientific literature. It provides semantic search across 138 million academic papers and 545,000 clinical trials, automates PRISMA 2020-compliant systematic literature reviews, generates customizable research reports with sentence-level citations, and exposes paper search and report generation through an API. The platform is sold via Basic, Plus, Pro, Teams, Institutional, and Enterprise subscription tiers to individual researchers, academic teams, and enterprise research organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Researchers report up to 80% time savings on systematic reviews
+6 more records
Product overview1 text field

Elicit is a single AI research-assistant platform composed of a core web application (elicit.com) plus several integrated modules and an API. The core platform is sold via Basic, Plus, Pro, Teams, and Enterprise plans and is organized around five top-level modules — Search, Research Reports, Systematic Literature Review, Library, and Alerts — that work together so a researcher can move from semantic literature discovery through to screening, extraction, and ongoing monitoring. On top of this core, Elicit has shipped specialized modules such as Research Agents (multi-step autonomous workflows introduced December 2025), Clinical Trials (search across 545,000 ClinicalTrials.gov studies introduced July 2025), and Mechanisms of Action (a pre-loaded AI Research Agent experience for drug-mechanism research), plus feature additions such as Strict Screening, 80-Paper Reports, and Keyword Search over PubMed and ClinicalTrials.gov inside Systematic Reviews. The Elicit API is the programmatic counterpart, exposing paper search and report generation to Teams, Pro, and Enterprise subscribers in preview, with subscription-tier rate limits and API-key authentication.

Product and service2 records
1Elicit
CategoryAI Research Software
Description

AI research assistant platform that uses language models to help researchers find, analyze, and synthesize scientific literature. The platform combines semantic search across 138 million academic papers and 545,000 clinical trials, PRISMA 2020-compliant systematic literature review automation, customizable AI-generated research reports (up to 80 papers) with sentence-level citations, persistent Library organization, and relevance-categorized Alerts. Sold via Basic (free), Plus, Pro, Teams, Institutional, and Enterprise subscription tiers to individual researchers, academic teams, and enterprises in pharma, biotech, academia, and government.

2Elicit API
CategoryDeveloper API
Description

Programmatic access to Elicit's paper search across 138 million academic papers and research report generation. Currently in preview, available to Pro, Teams, and Enterprise subscribers who opt in. Authenticated via API keys with subscription-tier rate limits (Pro: 100 papers per search request and 100 requests per day; Teams: 200 papers per search request and 200 requests per day). Use is restricted to internal scientific research workflows within an organization; building external commercial applications or training external ML models is prohibited.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Consensus is an AI search engine purpose-built for scientific research, drawing answers from peer-reviewed studies with citation-backed outputs. It is the closest direct competitor to Elicit, targeting the same individual researcher and enterprise life-sciences buyer with a similar freemium-to-paid SaaS model.

2SciSpace (Typeset)
TypeDirect peer
Description

SciSpace is an AI research assistant that helps researchers discover, read, and write scientific papers, including literature review and data extraction tooling. It competes head-to-head with Elicit in the academic and pharma end-markets and offers overlapping features such as semantic search and AI-generated summaries.

TypeDirect peer
Description

Scite uses AI to classify how scientific papers cite one another (supporting, contrasting, mentioning), providing citation-level evidence. It targets similar academic and enterprise researcher workflows as Elicit's Reports and Systematic Review modules and sells to individual researchers and institutions.

TypeDirect peer
Description

Iris.ai offers an AI engine for R&D that combines semantic search, analysis, and automated systematic review across scientific literature. It is a direct peer in the AI-for-research space, with particular strength in industrial R&D and life sciences — overlapping with Elicit's pharma/biotech and industrials segments.

TypeDirect peer
Description

Covidence is a dedicated systematic-review workflow tool used widely in academic and Cochrane-style reviews for screening, data extraction, and PRISMA-compliant workflows. It competes directly with Elicit's Systematic Literature Review module, particularly among academic and policy researchers.

6Rayyan
TypeDirect peer
Description

Rayyan is an AI-assisted systematic review platform used by researchers for screening, collaboration, and deduplication. It is a direct peer in the systematic-review and literature-screening workflow that Elicit is actively expanding into with PRISMA 2020 support.

TypeBroad incumbent
Description

Semantic Scholar is the Allen Institute's AI-powered academic search engine covering 200M+ papers with highly cited author and paper analytics. As a free, well-funded incumbent with overlapping semantic search functionality, it is a broad competitor to Elicit's core Search module but does not focus on enterprise systematic reviews or pharma workflows.

TypeEmerging player
Description

ResearchRabbit is an AI-powered literature mapping and discovery tool that visualizes related papers and authors. It overlaps with Elicit's discovery and Library workflows for academic researchers but is a free/discovery-focused tool rather than a full systematic-review platform.

TypeEmerging player
Description

Scholarcy is an AI summarization tool that turns long papers into structured summaries and flashcards. It competes with parts of Elicit's Reports and extraction value proposition in the academic and individual-researcher segment but lacks Elicit's depth in enterprise pharma workflows.

TypeEmerging player
Description

Connected Papers uses AI to visualize academic papers in a graph of related work, helping researchers explore prior literature. It overlaps with Elicit's literature-discovery use case for academics but is a focused, primarily-paid-individual tool rather than an enterprise systematic-review platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elicit

AI Research Assistant Softwareelicit.com

Elicit is an AI research assistant that uses LLMs to automate literature discovery, evidence extraction, and systematic reviews across 138 million academic papers and 545,000 clinical trials for academic, pharmaceutical, biotech, and policy researchers worldwide.

What Elicit does

Elicit is an AI-powered research assistant that uses large language models to help academic, pharmaceutical, biotech, policy, and other scientific researchers automate literature discovery, evidence extraction, and systematic review workflows. Founded in 2018 at the Ought research lab by Andreas Stuhlmüller (CEO, MIT PhD in cognitive science, Stanford postdoc) and Jungwon Byun (COO, ex-Head of Growth at Upstart, Yale economics), the company is incorporated as Elicit Research, PBC — a Delaware Public Benefit Corporation headquartered in Oakland, California with a distributed team across North America and Europe.

The platform is built around semantic search and retrieval-augmented generation across 138 million academic papers and 545,000 clinical trials, with keyword search support spanning PubMed and ClinicalTrials.gov. It is organized into five core modules — Search, Research Reports (customizable up to 80 papers), Systematic Literature Review (PRISMA 2020-compliant and benchmarked at 95–99% accuracy across 994 Cochrane reviews), Library, and Alerts — plus specialized modules for Clinical Trials, Research Agents (multi-step autonomous workflows), and a Mechanisms of Action content experience. Outputs are sentence-level citation-backed for verifiability, and the platform exposes programmatic access via the Elicit API (launched March 2026, tier-gated rate limits).

Revenue comes from a tiered SaaS subscription model (Basic free, Plus, Pro, Teams, Institutional, Enterprise) layered onto product-led self-serve signup, with a parallel enterprise field-sales motion targeting pharma, biotech, medtech, and life sciences organizations in the US and EMEA. The company has raised over $30 million in venture capital across a $9M seed round (September 2023, led by Fifty Years) and a $22M Series A (February 2025, led by Footwork and Spark Capital), with named customers including Formation Bio, Oxford PharmaGenesis, Genentech, Novartis, OpenAI, VDI/VDE, Harvard, MIT, and Stanford, and reports "millions of dollars of recurring revenue" roughly eighteen months after launching paid subscriptions.

Elicit firmographics

Firmographics
Name
Elicit
Legal name
Elicit Research, PBC
Website
https://elicit.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Elicit is an AI research assistant that uses LLMs to automate literature discovery, evidence extraction, and systematic reviews across 138 million academic papers and 545,000 clinical trials for academic, pharmaceutical, biotech, and policy researchers worldwide.
Ownership category
akta.pro rank

Elicit industry classification

Industry
Product category
AI Research Assistant Software
NAICS
Educational Support Services (611710), Research and Development in the Social Sciences and Humanities (54172)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYEDAFADAD
Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms

Keywords

  • AI research assistant
  • Systematic literature review
  • Scientific paper search
  • Evidence synthesis software
  • Clinical trial analysis

Where Elicit is headquartered

Location

Headquarters

HQ city
Oakland
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Elicit business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Subscription tiers: Tiered SaaS subscription: Elicit Basic (free), Elicit Plus, Elicit Pro, Elicit Teams, Elicit Institutional, and Elicit Enterprise. Plus, Pro, Teams, Institutional, and Enterprise are paid subscriptions; Teams is geared at purchasers with a separate Services Agreement. Enterprise is quote-based via Talk to Sales.
  2. Enterprise contracts: Large enterprise contracts with pharma, biotech, and life sciences organizations. Enterprise AEs are compensated on quota with OTE of $200K–$360K, suggesting seven-figure deal sizes and multi-year engagements. Land-and-expand motion: pilot programs, then multi-year, multi-team expansion.
  3. API access: API access is bundled into Pro, Teams, and Enterprise subscriptions — not sold as a standalone product. Usage is gated by rate limits: Pro users get 100 papers per search request and 100 search requests per day; Teams users get 200 papers per search request and 200 search requests per day. Report generation is limited by overall Elicit workflow quota.
  4. Freemium self-serve: Free tier (Basic) provides unlimited searches for free users (since July 2024), serving as a top-of-funnel conversion engine to Plus, Pro, and Teams paid tiers.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goElicit Basic — free tier with unlimited searches (phased out credits in July 2024)
SubscriptionMonthlyElicit Plus — paid individual tier
SubscriptionMonthlyElicit Pro — paid individual tier with API access
SubscriptionAnnualElicit Teams — paid team subscription with API access
SubscriptionMulti-year contractElicit Institutional and Enterprise — institutional/enterprise plans

Go-to-market motion4 records

Distribution channels4 records

Marketing channels10 records

Elicit product offering

Product offering

Core offering

Elicit is an AI research assistant platform that uses language models to help researchers find, analyze, and synthesize scientific literature. It provides semantic search across 138 million academic papers and 545,000 clinical trials, automates PRISMA 2020-compliant systematic literature reviews, generates customizable research reports with sentence-level citations, and exposes paper search and report generation through an API. The platform is sold via Basic, Plus, Pro, Teams, Institutional, and Enterprise subscription tiers to individual researchers, academic teams, and enterprise research organizations.

Product overview

Elicit is a single AI research-assistant platform composed of a core web application (elicit.com) plus several integrated modules and an API. The core platform is sold via Basic, Plus, Pro, Teams, and Enterprise plans and is organized around five top-level modules — Search, Research Reports, Systematic Literature Review, Library, and Alerts — that work together so a researcher can move from semantic literature discovery through to screening, extraction, and ongoing monitoring. On top of this core, Elicit has shipped specialized modules such as Research Agents (multi-step autonomous workflows introduced December 2025), Clinical Trials (search across 545,000 ClinicalTrials.gov studies introduced July 2025), and Mechanisms of Action (a pre-loaded AI Research Agent experience for drug-mechanism research), plus feature additions such as Strict Screening, 80-Paper Reports, and Keyword Search over PubMed and ClinicalTrials.gov inside Systematic Reviews. The Elicit API is the programmatic counterpart, exposing paper search and report generation to Teams, Pro, and Enterprise subscribers in preview, with subscription-tier rate limits and API-key authentication.

Differentiator

Problem solved

Functional benefit

Products and services

  • Elicit AI research assistant platform that uses language models to help researchers find, analyze, and synthesize scientific literature. The platform combines semantic search across 138 million academic papers and 545,000 clinical trials, PRISMA 2020-compliant systematic literature review automation, customizable AI-generated research reports (up to 80 papers) with sentence-level citations, persistent Library organization, and relevance-categorized Alerts. Sold via Basic (free), Plus, Pro, Teams, Institutional, and Enterprise subscription tiers to individual researchers, academic teams, and enterprises in pharma, biotech, academia, and government.
  • Elicit API Programmatic access to Elicit's paper search across 138 million academic papers and research report generation. Currently in preview, available to Pro, Teams, and Enterprise subscribers who opt in. Authenticated via API keys with subscription-tier rate limits (Pro: 100 papers per search request and 100 requests per day; Teams: 200 papers per search request and 200 requests per day). Use is restricted to internal scientific research workflows within an organization; building external commercial applications or training external ML models is prohibited.

Quantifiable outcome

  • Researchers report up to 80% time savings on systematic reviews
  • +6 more outcomes

Companies that use Elicit

Customer profile

Named customers11 records

Segments7 records

Ideal customer profiles3 records

Elicit technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability9 records

Feature10 records

Elicit partnerships and signals

Strategic signal

Scale indicators12 records

Expansion highlights6 records

Elicit competitors and assessment

Company assessment

Direct peers

  • Consensus: Consensus is an AI search engine purpose-built for scientific research, drawing answers from peer-reviewed studies with citation-backed outputs. It is the closest direct competitor to Elicit, targeting the same individual researcher and enterprise life-sciences buyer with a similar freemium-to-paid SaaS model.
  • SciSpace (Typeset): SciSpace is an AI research assistant that helps researchers discover, read, and write scientific papers, including literature review and data extraction tooling. It competes head-to-head with Elicit in the academic and pharma end-markets and offers overlapping features such as semantic search and AI-generated summaries.
  • Scite.ai: Scite uses AI to classify how scientific papers cite one another (supporting, contrasting, mentioning), providing citation-level evidence. It targets similar academic and enterprise researcher workflows as Elicit's Reports and Systematic Review modules and sells to individual researchers and institutions.
  • Iris.ai: Iris.ai offers an AI engine for R&D that combines semantic search, analysis, and automated systematic review across scientific literature. It is a direct peer in the AI-for-research space, with particular strength in industrial R&D and life sciences — overlapping with Elicit's pharma/biotech and industrials segments.
  • Covidence: Covidence is a dedicated systematic-review workflow tool used widely in academic and Cochrane-style reviews for screening, data extraction, and PRISMA-compliant workflows. It competes directly with Elicit's Systematic Literature Review module, particularly among academic and policy researchers.
  • Rayyan: Rayyan is an AI-assisted systematic review platform used by researchers for screening, collaboration, and deduplication. It is a direct peer in the systematic-review and literature-screening workflow that Elicit is actively expanding into with PRISMA 2020 support.

Broad incumbents

  • Semantic Scholar: Semantic Scholar is the Allen Institute's AI-powered academic search engine covering 200M+ papers with highly cited author and paper analytics. As a free, well-funded incumbent with overlapping semantic search functionality, it is a broad competitor to Elicit's core Search module but does not focus on enterprise systematic reviews or pharma workflows.

Emerging players

  • ResearchRabbit: ResearchRabbit is an AI-powered literature mapping and discovery tool that visualizes related papers and authors. It overlaps with Elicit's discovery and Library workflows for academic researchers but is a free/discovery-focused tool rather than a full systematic-review platform.
  • Scholarcy: Scholarcy is an AI summarization tool that turns long papers into structured summaries and flashcards. It competes with parts of Elicit's Reports and extraction value proposition in the academic and individual-researcher segment but lacks Elicit's depth in enterprise pharma workflows.
  • Connected Papers: Connected Papers uses AI to visualize academic papers in a graph of related work, helping researchers explore prior literature. It overlaps with Elicit's literature-discovery use case for academics but is a focused, primarily-paid-individual tool rather than an enterprise systematic-review platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Elicit social profiles

Digital presence

Elicit compliance and trust

Trust signal

Compliance2 records

Elicit financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elicit leadership team

Management profile

Number of profiles

Profiles5 records

Elicit funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elicit M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elicit

What does Elicit do?

Elicit is an AI research assistant platform that uses language models to help researchers find, analyze, and synthesize scientific literature. It provides semantic search across 138 million academic papers and 545,000 clinical trials, automates PRISMA 2020-compliant systematic literature reviews, generates customizable research reports with sentence-level citations, and exposes paper search and report generation through an API. The platform is sold via Basic, Plus, Pro, Teams, Institutional, and Enterprise subscription tiers to individual researchers, academic teams, and enterprise research organizations.

Is Elicit a public or private company?

Elicit is a private company. It is classified as venture growth investor backed and is currently operating.

When was Elicit founded?

Elicit was founded in 2018. It employs 51 to 100 people.

Where is Elicit based?

Elicit is headquartered in Oakland, United States, in the North America region.

How does Elicit make money?

Four revenue lines are on record. Subscription tiers are the primary driver. The others are enterprise contracts, API access and freemium self-serve.

Who are Elicit's main competitors?

Direct peers on record are Consensus, SciSpace (Typeset), Scite.ai, Iris.ai, Covidence and Rayyan. Semantic Scholar is listed as a broad incumbent. Emerging players are ResearchRabbit, Scholarcy and Connected Papers.

Does Elicit have an API?

Yes. The Elicit API provides programmatic access to Elicit platform features at scale, including paper search and research report generation. It is currently in preview status. The API is available only to users with an active Teams, Pro, or Enterprise subscription who opt in. Authentication is via API keys issued by Elicit. Rate limits: Pro users 100 papers per search request and 100 search requests per day; Teams users 200 papers per search request and 200 search requests per day; report generation is limited by overall Elicit workflow quota. Rate limits are enforced at the account level using a rolling 24-hour window. The API may not be used to build commercial applications or products for external distribution, to train or improve machine learning models, or to systematically replicate the Elicit paper corpus. Outputs are AI-generated, non-deterministic, and produced by multiple models that may change without notice. Models and behaviors may change without notice; pre-signed download URLs for reports expire after 7 days; cached outputs may be retained up to 30 days. Developer documentation is at docs.elicit.com.

What industry is Elicit in?

Elicit's product category is AI Research Assistant Software. Its primary akta.pro industry code is EDAFADAD, Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms. Its NAICS code is 611710 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScienmagAI Tools Extract Qualitative Fisheries Data but Require Rigorous HumanA pilot study compared three AI tools to human reviewers for extracting qualitative data from community-based fisheries management papers. The tools showed poor agreement on data presence, with Cohen's kappa below 0.10, and Elicit outperformed GPT-4 variants. The authors conclude that human oversight remains essential for complex ecological literature reviews.MDPIProtocolNerd: An Interactive AI Research Assistant for Scientific Protocol DiscoveryProtocolNerd is a web-based assistant that helps biologists and chemists find experimental protocols by describing experiments in plain English and answering follow-up questions. It uses TF-IDF and semantic search, plus PubMed queries, and placed the correct protocol in top 10 results 46% of the time on a benchmark, significantly outperforming Elicit, Consensus, and Perplexity.36krAI for Academic Paper Writing: Leveraging Research-Dedicated AI to Secure the Next-Generation Scientific Innovation EdgeA Nature study estimated nearly 90% of biomedical papers showed AI-assisted writing by December 2025, with annual averages of 77% in 2025 and 52% in 2024. The analysis detected AI signals in linguistic sections like abstracts and discussions, while methods sections showed lower signals. Products are shifting from paper generation to embedding AI into the full research workflow.TechBullion6 Best AI Tools for a Literature Review in 2026A guide compares five AI tools for conducting literature reviews, ranking them by task: Canyam for unified academic discovery, Elicit for systematic screening and data extraction, Consensus for evidence-based answers, Scite for citation-context checks, and Semantic Scholar and ResearchRabbit for free search and citation mapping. It advises combining tools while retaining human judgment for study selection, quality assessment and interpretation.The Times of IndiaTop AI Tools for Research Writing, Papers, and CitationsThe article discusses the top AI tools for research writing in 2026, including Perplexity AI, Elicit, Consensus, ChatGPT, and Zotero, which help users find sources, analyze papers, organize citations, and write more efficiently. These tools reduce the time spent on research processes such as searching, reading, and synthesizing information. They enable researchers to focus more on understanding and structuring their research content, transforming traditional workflows.Paperguide9+ Best AI Tools for Scientific Research in 2026This article is a comparative product guide ranking 11 AI tools for scientific research in 2026, evaluating platforms including Paperguide, Paperpal, SciSpace, Elicit, NotebookLM, Semantic Scholar, ResearchRabbit, Scite, Consensus, Scholarcy, and Julius AI across features, pricing, and use cases. The guide designates Paperguide as the best overall AI research platform based on its end-to-end workflow coverage spanning literature discovery, screening, data extraction, citation management, and academic writing in a single workspace. The article also identifies free alternatives such as Semantic Scholar, ResearchRabbit, and NotebookLM as strong options for researchers on a budget, while noting that most major academic publishers now permit AI-assisted research with proper disclosure.Help Net SecurityAI prompt confidentiality and false citations worry researchersA think-aloud study conducted by researchers at the University of Texas at Austin and Microsoft observed 15 academic researchers using commercial AI tools (Research Rabbit and Elicit AI) for literature review and idea generation, finding that participants routinely entered unpublished research questions and draft hypotheses into systems with unresolved confidentiality and output verification concerns. The study identified that nine of 15 participants struggled to verify AI-generated content sources, with all 15 developing compensatory strategies such as manual verification and restricting AI to low-stakes tasks due to documented failure modes including attribution displacement and synthetic blending of fabricated citations. The authors note the same vulnerabilities apply to enterprise environments where employees expose internal documents to opaque commercial LLMs, recommending slower AI adoption supported by verification pipelines and clearer vendor data governance disclosures.IntuitionLabsHow AI Literature Review Tools Work: RAG & Semantic SearchThis article provides an in-depth technical analysis of how AI literature review tools function, covering core components such as semantic search, retrieval-augmented generation (RAG), machine learning ranking, and language model summarization. The report highlights specific platforms including Semantic Scholar, Elicit, Rayyan, and Iris.ai, presenting performance data showing that systematic reviews can be completed in 12 days using AI-assisted workflows versus 67 weeks through traditional methods. The article also discusses ongoing challenges like AI hallucinations, coverage bias in English-dominated corpora, and future developments including multimodal models, knowledge graph integration, and interactive AI research assistants.RdworldonlineClaude Opus 4.6 targets research workflows with 1M-token context window, improved scientific reasoningAnthropic released Claude Opus 4.6 on February 5, featuring a 1M-token context window that achieved 76% on the MRCR v2 long-context benchmark compared to its predecessor's 18.5%, representing what Anthropic calls a qualitative shift in usable context performance. The model scored approximately 144 Elo points higher than OpenAI's GPT-5.2 on the GDPval-AA economically valuable knowledge work evaluation and led all released frontier models on multiple benchmarks including agentic coding, complex reasoning, and scientific tasks. Third-party validation from Elicit confirmed an 85% recall rate on biopharma competitive intelligence benchmarks, with early testing supporting Anthropic's claims of near-doubling performance on computational biology, structural biology, organic chemistry, and phylogenetics benchmarks.TimeshighereducationBeyond search: how AI agents are redefining researchThis article, written by University of Alberta professor Ali Shiri, explores how a new generation of AI research assistants built on large language models is transforming academic research by enabling faster literature searches, systematic reviews, and data synthesis. It provides an in-depth review of three tools — Consensus, Elicit, and Undermind — highlighting their capabilities, data sources (primarily Semantic Scholar, PubMed, and OpenAlex), and limitations for researchers and graduate students. The author argues that as AI research agents grow more capable, there is an urgent need for structured AI literacy training in higher education to ensure ethical and effective use in scholarly practice.